SXTC vs SBFM vs CHNR vs TCMD vs CODA

For growth investors, Sunshine Biopharma, Inc.

(SBFM) is the stronger pick with 44. 7% revenue growth year-over-year, versus -9. 7% for China SXT Pharmaceuticals, Inc. (SXTC). Tactile Systems Technology, Inc. (TCMD) offers the better valuation at 31. 7x trailing P/E (22. 8x forward), making it the more compelling value choice. Analysts rate Tactile Systems Technology, Inc. (TCMD) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Tactile Systems Technology, Inc.

(TCMD) is the cheapest at 31. 7x versus Coda Octopus Group, Inc. at 32. 2x. On forward P/E, Coda Octopus Group, Inc. is actually cheaper at 22. 5x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Coda Octopus Group, Inc.

(CODA) delivered a total return of +49. 7%, compared to -100. 0% for Sunshine Biopharma, Inc. (SBFM). Over 10 years, the gap is even starker: CODA returned +844. 4% versus SBFM's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Tactile Systems Technology, Inc.

(TCMD) is the lower-risk stock at 0. 99β versus Sunshine Biopharma, Inc. 's 1. 31β — meaning SBFM is approximately 32% more volatile than TCMD relative to the S&P 500. On balance sheet safety, Coda Octopus Group, Inc. (CODA) carries a lower debt/equity ratio of 1% versus 7% for Tactile Systems Technology, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Sunshine Biopharma, Inc.

(SBFM) is pulling ahead at 44. 7% versus -9. 7% for China SXT Pharmaceuticals, Inc. (SXTC). On earnings-per-share growth, the picture is similar: Sunshine Biopharma, Inc. grew EPS 97. 9% year-over-year, compared to -129. 1% for China SXT Pharmaceuticals, Inc.. Over a 3-year CAGR, SBFM leads at 434. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Coda Octopus Group, Inc.

(CODA) is the more profitable company, earning 15. 5% net margin versus -189. 8% for China SXT Pharmaceuticals, Inc. — meaning it keeps 15. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CODA leads at 17. 1% versus -154. 0% for SXTC. At the gross margin level — before operating expenses — TCMD leads at 75. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Coda Octopus Group, Inc.

(CODA) trades at 22. 5x forward P/E versus 22. 8x for Tactile Systems Technology, Inc. — 0. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TCMD: 49. 0% to $38. 75.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Coda Octopus Group, Inc.

(CODA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 00), +844. 4% 10Y return). Both have compounded well over 10 years (CODA: +844. 4%, SBFM: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SXTC (Healthcare) and SBFM (Healthcare) and CHNR (Industrials) and TCMD (Healthcare) and CODA (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SXTC is a small-cap quality compounder stock; SBFM is a small-cap high-growth stock; CHNR is a small-cap quality compounder stock; TCMD is a small-cap quality compounder stock; CODA is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.